Synthesis of Novel Potent Dipeptidyl Peptidase IV Inhibitors with Enhanced Chemical Stability: Interplay between the N-Terminal Amino Acid Alkyl Side Chain and the Cyclopropyl Group of α-Aminoacyl- l -cis-4,5-methanoprolinenitrile-Based Inhibitors
Year: 2004
Type: article
Abstract: A series of methanoprolinenitrile-containing dipeptide mimetics were synthesized and assayed as inhibitors of the N-terminal sequence-specific serine protease dipeptidyl peptidase IV (DPP-IV). The catalytic action of DPP-IV is the principle means of degradation of glucagon-like peptide-1, a key mediator of glucose-stimulated insulin secretion, and DPP-IV inhibition shows clinical benefit as a novel mechanism for treatment of type 2 diabetes. However, many of the reversible inhibitors to date suffer from chemical instability stemming from an amine to nitrile intramolecular cyclization. Installation of a cyclopropyl moiety at either the 3,4- or 4,5-position of traditional 2-cyanopyrrolidide proline mimetics led to compounds with potent inhibitory activity against the enzyme. Additionally, cis-4,5-methanoprolinenitriles with beta-branching in the N-terminal amino acid provided enhanced chemical stability and high inhibitory potency. This class of inhibitors also exhibited the ability to suppress prandial glucose elevations after an oral glucose challenge in male Zucker rats.
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm049924d
Authors: David R. Magnin, Jeffrey A. Robl, Richard B. Sulsky, David J. Augeri, Yanting Huang, Ligaya M. Simpkins, Prakash C. Taunk, David A. Betebenner, James G. Robertson, Benoni E. Abboa-Offei, Aiying Wang, Michael Cap, Li Xin, Li Tao, Doree F. Sitkoff, Mary F. Malley, Jack Z. Gougoutas, Ashish Khanna, Qi Huang, Song-Ping Han, Rex A. Parker, Lawrence G. Hamann
Institution: Bristol-Myers Squibb (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2027725447